Investor
The new money will go towards developing and improving the company's FitMi system.
OOVA uses urinalysis to deliver personalized fertility reports.
The Series A round was lead by BlueCross BlueShield Venture Partners, and brings the company's total funding to more than $10 million.
The company plans to put the new money towards improving its mobile platform and increasing its library of contents.
The company plans to use the new money for scaling its technology and expanding across the US.
The fund will focus on established businesses in the Benelux and DACH regions of Europe.
The company's technology could be incorporated into steering wheels, wearables and more.
The US Venture Partners-led Series B round will help HealthJoy expand its staff at home and abroad.
The acqusition will help expand Zoll Medical's charting services to EMS organizations of various sizes.
According to a Wall Street Journal report, the digital chronic disease management company is eyeing a $1B-plus valuation.